| |
| |
|
| Insider
Information: |
Young Diane C. |
| Relationship: |
|
| City: |
Memphis |
| State: |
TN |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
93,051 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$1,726,012 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
93,051 |
|
|
| Total
Value |
$1,726,012 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
1
|
2
|
|
Stock
price went up :
|
1
|
0
|
| Stock
price went down : |
0
|
2
|
| |
|
|
|
Gain/Loss Ratio : |
1.0
|
-2.0
|
| Percentage
Gain/Loss : |
 187.8%
|
 -14.4%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Oncternal Therapeutics Inc |
ONCT |
VP, Chief Medical Offi... |
2018-07-16 |
45,936 |
2016-10-28 |
0 |
Premium* |
|
|
Celldex Therapeutics Inc |
CLDX |
|
2022-08-17 |
47,115 |
2020-06-11 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
11 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| CLDX |
Celldex Therapeutics Inc |
SVP, CHIEF MEDICAL OFFICER |
• – – |
2022-08-17 |
4 |
OE |
$2.71 |
$319,170 |
D/D |
64,000 |
47,115 |
0 |
- |
|
| CLDX |
Celldex Therapeutics Inc |
SVP, CHIEF MEDICAL OFFICER |
• – – |
2022-08-17 |
4 |
S |
$37.30 |
$708,715 |
D/D |
(19,000) |
2,115 |
0 |
% |
|
| CLDX |
Celldex Therapeutics Inc |
SVP, Chief Medical Officer |
• – – |
2021-11-12 |
4 |
S |
$42.94 |
$197,529 |
D/D |
(4,600) |
2,115 |
0 |
% |
|
| CLDX |
Celldex Therapeutics Inc |
SVP, Chief Medical Officer |
• – – |
2021-11-12 |
4 |
OE |
$10.38 |
$47,748 |
D/D |
4,600 |
6,715 |
0 |
- |
|
| CLDX |
Celldex Therapeutics Inc |
SVP, Chief Medical Officer |
• – – |
2020-06-11 |
4 |
B |
$4.73 |
$10,004 |
D/D |
2,115 |
2,115 |
2.74 |
% |
|
| ONCT |
Oncternal Therapeutics In... |
VP, Chief Medical Officer |
• – – |
2018-07-16 |
4 |
S |
$14.70 |
$30,120 |
D/D |
(2,049) |
45,936 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
VP, Chief Medical Officer |
• – – |
2018-07-16 |
4/A |
S |
$14.70 |
$30,120 |
D/D |
(2,049) |
45,936 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
VP, Chief Medical Officer |
• – – |
2018-07-13 |
4 |
D |
$14.92 |
$30,049 |
D/D |
(2,014) |
47,985 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
VP, Chief Medical Officer |
• – – |
2018-07-13 |
4/A |
D |
$14.92 |
$30,049 |
D/D |
(2,014) |
47,985 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
VP, Chief Medical Officer |
• – – |
2016-10-28 |
4 |
S |
$7.70 |
$3,850 |
I/I |
(500) |
0 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
VP, Chief Medical Officer |
• – – |
2015-07-13 |
4 |
A |
$0.00 |
$0 |
D/D |
500,000 |
500,000 |
0 |
- |
|
11 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
